Carotid intima-media thickness (CIMT) has been shown to predict cardiovascular (CV) risk in multiple large studies.
. Nonetheless, most insurers consider CIMT and plaque assessment as investigational and the data to be insufficient and contradictory to justify reimbursement of CIMT for CV risk assessment (5) . This is similar to assessment for CAC, which is considered investigational by insurers (6) .
Along the same lines the recent US national guidelines recommend against performing CIMT in routine SEE PAGE 1054 clinical practice for prediction of CV events (7) . This article reviews studies that evaluated CIMT for CV risk stratification and risk prediction and discusses methodological variability that accounts for differences in findings among studies that has caused confusion about the role of IMT in CV risk prediction.
The article summarizes studies using CIMT and plaque in CVD risk association or prediction and discusses the emerging role of carotid plaque as a better marker of CVD risk than CIMT.
CIMT MEASUREMENT
CIMT is measured between the intimal- The development of automated edge-tracking software, which obviated the need to perform manual measurements, further improved the reproducibility of CIMT measurements (12) .
CIMT ASSESSMENT IN CLINICAL STUDIES OF CVD RISK PREDICTION
The carotid artery includes 4 segments, beginning with the CCA. This gives rise to the carotid bulb from which arise the external carotid artery and the internal carotid artery (ICA) (Figure 2) . Large clinical studies that measured CIMT to determine its value in predicting incident CVD are listed in Table 1 . These CIMT studies varied in the comprehensiveness with which CIMT was assessed. Some imaged only 1 side of the neck, whereas others imaged bilaterally ( Table 1) . Some included imaging of a single segment (13) ; others imaged multiple segments (14) (15) (16) . Some studies imaged the far wall of multiple segments (17) , whereas others imaged both near and far walls (4, 18, 19) . Far wall measurements of the CCA alone have been favored because the CCA is perpendicular to the ultrasound beam, easily assessable, and reproducible (8) (9) (10) , whereas the carotid bulb and ICA lie at an oblique angle and are more difficult to image (12) . Studies also differed in the type of IMT measurements made (mean or maximum for single measurements, mean of the mean, or mean of the maximum for multiple measurements), varying definition of plaque, whether plaques were included in the IMT measurements, and the different arbitrary cutoff points for CIMT to predict risk. Because of the focal nature of the atherosclerotic process (Figures 2 and 3A) , IMT measurements at 1 site can be very different from those taken at another site (14) ; hence, measuring CIMT from a single site can lower the sensitivity of detecting atherosclerotic changes.
Other differences in imaging protocol include the angle from which CIMT is assessed. Some studies imaged only from a single angle (13, 20) , whereas others imaged from multiple angles (17, 18, 21) . Imaging from a single angle does not completely evaluate the carotid artery in 3 dimensions. Atherosclerosis tends to form at the carotid bulb, particularly toward the outer wall where the shear stresses are low and oscillations in shear stresses are high (22) . Extensive ultrasound protocols are required to fully evaluate the degree of atherosclerotic burden and observe a treatment effect (23) . The phase of the cardiac cycle (end-systole vs.
end-diastole) when CIMT is measured also differs among studies. Because of systolic lumen diameter expansion that leads to thinning of CIMT during systole, CIMT values obtained from end-systole are lower than those obtained in end-diastole (24) .
The Kuoppio Ischaemic Heart Disease study was the first study to demonstrate an association of CIMT with future coronary events. In this study, every 0.1-mm increment of IMT was associated with an 11% increased risk of myocardial infarction (MI) during follow-up (25) . Subsequently, several other large clinical studies, including the ARIC (Atherosclerosis Risk in Communities) study (17) , the CHS (Cardiovascular Health Study) (26) , the CAPS (Carotid Atherosclerosis Progression Study) (27) , the MDCS (Malmo Diet and Cancer Study) (28) , and the Rotterdam Study (29) , all showed that CIMT can be used to assess incident CVD risk. Plaque presence seemed to have a more profound effect on improving risk prediction in women than in men.
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Framingham risk score (FRS) have been largely negative. In the MESA (Multi-Ethnic Study of Atherosclerosis), CCA-IMT did not predict either coronary artery disease or stroke risk after adjusting for the FRS (area under the curve of 0.78 for risk factors plus CIMT vs. 0.77 for risk factors alone in both models) (30) . Another study found the area under the curve of 0.69 for CIMT and FRS versus 0.66 for FRS (31) . The CAPS showed that even though CIMT was significantly and independently predictive of CV events, when added to the FRS and the European cardiovascular disease risk assessment model systemic coronary risk evaluation (SCORE) models, it did not consistently improve the risk classification of individuals (27) . A review of the CIMT studies by Simon et al. (32) shows that in some studies, CIMT added little to the coronary heart disease (CHD) prediction by risk factors, as judged by c-statistic and receiver-operating characteristic curve analysis and that the CHD prediction by CIMT was inferior to that by carotid plaque.
Meta-analyses of CIMT studies have also yielded contradictory results. The first meta-analysis that included major clinical studies with CIMT assessment of single or multiple carotid segments showed that for every 0.1-mm increase in CIMT, the future risk of myocardial infarction (MI) increases by 10% to 15% (33) . A second meta-analysis that evaluated CCA-IMT alone and excluded CCA or bulb IMT or plaques in 45,828 patients from 14 population-based studies showed that the addition of CIMT does not add clinically meaningful information to the standard prediction modalities (34, 35) . The Net Reclassification Index (NRI) with the addition of CCA-IMT was only 0.8% for the overall cohort and 3.6% for those at intermediate (36) . These differences can partly be explained by the fact that in the ARIC study, ICA IMT was only measurable in 43% of study subjects (17) .
Hence, in majority of subjects, combined IMT essentially represented CCA and bulb IMT, and plaque can be a representative of bulb IMT because majority of plaques form at the bulb. More recent studies, with better ability to image ICA-IMT due to an improvement in ultrasound imaging techniques and pixel resolution, found that ICA-IMT is associated with higher relative risk of incident CVD compared with CCA-IMT (37).
Studies have found greater prediction of stroke by CCA-IMT (30), whereas ICA-IMT appears to predict atherosclerotic cardiac events better (16) . In the MESA study (38) , age-, race-, and sex-adjusted risk of stroke Table 1) . Some studies specifically exclude plaque and selectively measure CIMT in a plaque-free region (44). Others include plaque when measuring CIMT (17) . Figure 3A shows a patient with a focal nonobstructive carotid plaque with acoustic shadowing at the far wall of the carotid bulb. In this case, the CCA-IMT is thin and normal. If CIMT is measured in the plaque-free CCA, the CIMT value would be in the normal range, and this patient's CV risk as predicted by CIMT would be misclassified as being low. This is in contrast to the patient in Figure 3B , who has a focal long plaque but also has thickening of the CIMT in the plaque-free area. In this patient, the CIMT value would be abnormal. Importantly, near-wall IMT in all segments appears thicker than far-wall IMT in this patient, but near-wall IMT was often not measured or reported in several studies that may have led to underestimation of CVD risk.
CIMT studies have varied widely in how plaques are defined and how the plaque data are analyzed. The transition from an increased CIMT to plaque is arbitrarily defined, and it is debated whether the transition from increased carotid IMT to carotid plaque formation is a continuous process (45) or whether carotid IMT and plaques are separate phenotypes (40) .
Plaque definition used in some studies may represent In studies in which plaques are taken into consideration, the way in which plaques are analyzed differs. Table 2 lists studies in which carotid plaque was evaluated as a prognostic predictor of CV events. In some studies, plaque assessment is qualitative, in which the presence or absence of plaques was recorded and analyzed categorically as either "yes" or "no" Some studies show that "plaque phenotypes" such as plaque irregularity (57) , and plaque calcification (44) add to CV risk prediction. Figure 3 illustrates the variability in plaque size and appearance. Figure 3C shows a patient with multiple plaques in the carotid bulb, and Figure 3D shows a patient with a large calcified layered plaque along the carotid vessel wall. Thus, plaques differ in their morphology and composition, and simply categorizing plaque as "yes"
and "no" clearly fails to capture plaque complexity and its implications for CV risk. CAFES-CAVE ¼ carotid-femoral morphology and cardiovascular events; CHD ¼ coronary heart disease; CVA ¼ cerebrovascular accident; other abbreviations as in Table 1 . These studies suggest that carotid plaque has predictive power for incident atherosclerotic heart disease. Plaques tend to form at the carotid bulb and at the ICA. This may explain why IMT measurements from these segments are good predictors of CV events, whereas IMT measurements from the CCA alone or IMT measurements that specifically exclude plaque are less predictive of atherosclerotic cardiac disease. Because increased CCA-IMT is associated with an increased stroke risk, combined assessment of FRS, IMT, and plaque may enhance prediction of total CVD (70).
ASSOCIATION OF CIMT AND PLAQUE WITH RISK FACTORS
Another clue to the link between CIMT and plaque in CVD risk prediction comes from their association with risk factors. The British Regional Heart Study, in which CCA far-wall IMT was measured along with bulb IMT and plaque, found that CCA-IMT and bulb IMT were correlated with each other but showed differing patterns of association with risk factors and prevalent atherosclerotic disease (71). CCA-IMT was strongly Naqvi and Lee
associated with risk factors for stroke and with prevalent stroke, whereas bulb IMT and plaque were more directly associated with ischemic heart disease risk factors and prevalent ischemic heart disease. IMT is strongly influenced by genetic determinants, but plaque appears to be determined by common CHD risk factors such as age, sex, hypertension, diabetes mellitus, hypercholesterolemia, amount of nicotine consumed, factor VIII, and von Willebrand factor but not genetic inheritance (72) . Plaques also correlate with other measures of atherosclerotic vascular disease, such as aortic stiffness, whereas no such association was found for CIMT (73) . In particular, echogenic plaques are associated with increased arterial stiffness 
UTILITY OF IMT IN YOUTHS
CIMT provides a measurable reliable marker of the atherosclerotic disease process in the young, a group in whom vascular events will not occur for decades and in whom plaque formation or calcification has not occurred (90) . Mean CCA-IMT, bulb, and ICA-IMT were Combined CIMT and plaque assessment appear better than either measure alone. 3D plaque volume correlates with CAC score. In the future, plaque progression and regression assessed by 3D ultrasound may serve as a powerful tool to evaluate the effect of CV therapy.
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